日本国产一卡二卡三新区,国产精品福利免费,四虎国产最新永久在线

當(dāng)前位置: 首頁 » 產(chǎn)品 » 搜索

Ciprofibrate D6
Ciprofibrate D6 is deuterium labeled Ciprofibrate, which is a peroxisome proliferator-activated receptor agonist. 公司介
2015-12-21 16:56 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

1100.00/1mg
01mg起訂

HY-17557
Calcium N5-methyltetrahydrofolate(NSC173328) is the calcium salt of levomefolic acid, which has been proposed for treatm
2015-12-21 16:54 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

3255.00/5mg
05mg起訂

Levoleucovorin (Calcium)
Levoleucovorin calcium is the calcium salt of Levoleucovorin, which is the enantiomerically active form of folinic acid.
2015-12-21 16:52 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

650.00/5mg
05mg起訂

Topotecan (Hydrochloride)
Topotecan Hcl (SKF 104864A; NSC 609669) is the first topoisomerase I-directed cytotoxic agent to enter clinical trials i
2015-12-21 16:51 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

500.00/10mg
010mg起訂

AZ20
AZ20 is a potent and selective inhibitor of ATR with an IC50 of 5 nM; 8-fold selectivity over mTOR(IC50=38 nM).IC50 Valu
2015-12-21 16:49 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

1972.00/10mg
010mg起訂

SAR407899 (hydrochloride)
SAR407899 Hcl is a potent, ATP-competitive ROCK inhibitor woth Ki value of 36 nM/41 nM for human ROCK/Rat ROCK respectiv
2015-12-21 16:47 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

3500.00/5mg
05mg起訂

Balaglitazone
Balaglitazone (DRF-2593; NN-2344) is a novel partial agonist of PPAR-.IC50 Value:Target: PPARin vitro: The Rs for the se
2015-12-21 16:45 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

13020.00/100mg
0100mg起訂

PCI-34051
PCI-34051 is a specific inhibitor of HDAC8 with IC50 of 10 nM, with 200-fold selectivity over the other HDAC isoforms.IC
2015-12-21 16:44 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

1252.00/10mg
010mg起訂

Romidepsin
Romidepsin (FK228, depsipeptide) is a potent HDAC1 and HDAC2 inhibitor with IC50 of 36 nM and 47 nM, respectively.IC50 V
2015-12-21 16:41 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

2980.00/1mg
01mg起訂

AZD1152
AZD1152 (barasertib), pro-drug of barasertib-hQPA(HY-10126), is a selective Aurora B kinase inhibitor, AZD1152 inhibited
2015-12-21 16:39 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

1228.00/5mg
05mg起訂

AT13387
AT13387 is a selective potent Hsp90 inhibitor with IC50 of 18 nM in A375 cells, displays a long duration of anti-tumor a
2015-12-21 16:38 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

1989.00/5mg
05mg起訂

ACY-1215
Rocilinostat (ACY-1215) is a selective HDAC6 inhibitor with IC50 of 5 nM; 10-fold more selective for HDAC6 than HDAC1/2/
2015-12-21 16:36 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

1252.00/10mg
010mg起訂

sirtuin modulator
6-phenylimidazo[2,1-b]thiazole derivatives; sirtuin modulator.公司介紹：MedChemExpress(MCE)專注于各種抑制劑、激動劑、API
2015-12-21 16:34 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

2372.00/5mg
05mg起訂

Voreloxin (Hydrochloride)
Voreloxin Hcl(SNS-595; AG 7352) is a small molecule and a naphthyridine analogue with antineoplastic activity; inhibitor
2015-12-21 16:32 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

2558.00/5mg
05mg起訂

BMS-265246
BMS-265246 is a potent and selective CDK1/2 inhibitor for CDK1/cyclin B and CDK2/cyclin E with IC50 of 6 nM and 9 nM, re
2015-12-21 16:30 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

1989.00/5mg
05mg起訂

Alvespimycin
Alvespimycin (17-DMAG; KOS-1022; NSC 707545) is a potent, water-soluble HSP90 inhibitor with IC50 of 62 nM.IC50 Value: 6
2015-12-21 16:28 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

2727.00/100mg
0100mg起訂

MLN0905
MLN0905 is a small-molecule and potent inhibitor of PLK1 with IC50 of 2 nM.IC50 Value: 2 nMTarget: PLK1in vitro: MLN0905
2015-12-21 16:26 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

2346.00/10mg
010mg起訂

BIBR 1532
BIBR 1532 is a potent, selective, non-competitive telomerase inhibitor with IC50 of 100 nM.IC50 Value: 100 nMTarget: Tel
2015-12-21 16:22 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

837.00/10mg
010mg起訂

17-AAG (Hydrochloride)
17-AAG Hcl is a potent HSP90 inhibitor with IC50 of 5 nM, having a 100-fold higher binding affinity for HSP90 derived fr
2015-12-21 16:20 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

2744.00/100mg
0100mg起訂

CI-994
CI-994 (Tacedinaline) is an anti-cancer drug which inhibits HDAC1 with IC50 of 0.57 M and causes G1 cell cycle arrest.
2015-12-21 16:17 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]